Content about Neurochemistry

April 1, 2014

Smartphones and tablets may hold the key to getting more clinicians to screen patients for tobacco use and advise smokers on how to quit.

March 31, 2014

In an effort to curb abuse of over-the-counter cold and cough medications by minors, Washington Gov. Jay Inslee on Friday signed legislation — House Bill 2163 — that places an age restriction on the purchase of dextromethorphan.

February 18, 2014

This year, ECRM celebrates 20 years of successfully pairing buyers and sellers across the consumer packaged goods industry.

February 7, 2014

Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association joined forces to honor Chesterfield, Va.-based Substance Abuse Free Environment with this year’s Dose of Prevention award.

February 4, 2014

Reps. Bill Johnson, R-Ohio, and Bruce Braley, D-Iowa, last week introduced bipartisan legislation — the Preventing Abuse of Cough Medicine Treatment Act — that would help combat the abuse of dextromethorphan by placing an age restriction on its purchase.

January 13, 2014

The Consumer Healthcare Products Association on Friday pledged its support behind the introduction of legislation by Rep. Paul Harris, R-Wash., that would prohibit pharmacies or retail distributors from selling over-the-counter cough medicines containing dextromethorphan to those younger than 18 years without a prescription.

December 19, 2013

Abuse of the cough ingredient dextromethorphan among high school seniors is down, according to this year’s Monitoring the Future survey, which measures drug use and attitudes among the nation’s eighth-, 10th- and 12th-graders.

November 20, 2013

Through mid-November, a national registry of over-the-counter drugs considered chemical precursors to methamphetamine prevented more than 16,700 boxes of the drugs from being sold illegally.

November 7, 2013

Alleradd on Wednesday launched its namesake product — a dietary supplement product to help students focus as a healthy, quick-acting alternative to energy products with no harmful side effects.

November 4, 2013

The Food and Drug Administration has approved a new injectable painkiller made by Becton, Dickinson and Co., the medical products manufacturer said Monday.

October 25, 2013

The Food and Drug Administration plans to officially recommend that products containing 15 mg or less of the opioid painkiller hydrocodone be rescheduled as Schedule II controlled substances, from the current Schedule III classification. While the idea is to combat abuse and misuse of the drugs, pharmacy groups say the rescheduling would make them harder to obtain for patients who legitimately need them.

The desire to combat abuse and misuse of prescription drugs — now a worse problem in the United States than cocaine or heroin — is laudable, but unlike those two drugs, hydrocodone has a legitimate use as a painkiller, and it's the people who are using it properly and legally who will end up losing.

October 22, 2013

The Food and Drug Administration has approved drugs for depression and smoking cessation made by Jubilant Life Sciences, the company said.

October 14, 2013

USA Today on Monday morning reported two products marketed as dietary supplements in outlets including Walmart.com and GNC have actually been adulterated with a chemical similar to methamphetamine.

October 2, 2013

The Community Anti-Drug Coalitions of America and the Consumer Healthcare Products Association on Tuesday collaborated to spread awareness about over-the-counter cough medicine abuse among parents and communities in recognition of annual National Medicine Abuse Awareness Month.

September 30, 2013

New York Gov. Andrew Cuomo on Friday signed legislation to prohibit pharmacies and stores from selling dextromethorphan to any person younger than 18 years unless they have a prescription.

September 27, 2013

ScriptPro's Central Pharmacy Management System Point of Sale can now interface with a real-time system for tracking and controlling OTC products that can be used to manufacture methamphetamine.

September 19, 2013

A company that makes vending machine-like systems has a new business: medical and recreational marijuana.

September 5, 2013

Acura Pharmaceuticals announced a study, published in the September issue of the American Journal of Drug and Alcohol Abuse, that validates the ability of Nexafed to uniquely disrupt the extraction and conversion of pseudoephedrine into methamphetamine.

September 3, 2013

A new opioid painkiller drug made by Upsher-Smith Labs will become available on Wednesday, the drug maker said.

August 28, 2013

Fruth Pharmacy is taking up a pseudoephedrine product for nasal congestion designed to deter the manufacturing of methamphetamine at all of its stores, according to published reports.

August 8, 2013

Pennsylvania last month became the 29th state to employ the National Precursor Log Exchange in the fight against the diversion of products containing pseudoephedrine into methamphetamine. State No. 30, Delaware, is expected to sign real-time stop sale technology into law this summer.

July 17, 2013

New, abuse-deterrent formulations of two opioid painkillers have not necessarily reduced doctors' unease with prescribing them, according to a new study.

July 15, 2013

Acura Pharmaceuticals on Monday announced a second-generation prototype formulation of its methamphetamine-resistant IMPEDE technology with pseudoephedrine hydrochloride yielded no measurable amount of methamphetamine hydrochloride when processed in the direct conversion or one-pot method.

July 1, 2013

More than half of Americans suffer from motion sickness, according to a recent survey conducted on behalf of Prestige Brands' Dramamine, with as many as 60% indicating that they most often suffer while riding as a passenger in a car.

© 2014 Drug Store News. All Rights Reserved.